Conventional peptide therapy has frequently been constrained by reduced bioavailability and enzymatic stability. Nevertheless, novel approaches are driving a significant shift in peptide creation. These engineered https://bookmarkplaces.com/story21958498/transforming-drug-development-with-next-generation-short-proteins